What's new

Human medicines European public assessment report (EPAR): Tamiflu, oseltamivir, Date of authorisation: 20/06/2002, Revision: 43, Status: Authorised

Human medicines European public assessment report (EPAR): Tamiflu, oseltamivir, Date of authorisation: 20/06/2002, Revision: 43, Status: Authorised

Apr 15, 2025 - 16:32
 0
Human medicines European public assessment report (EPAR): Tamiflu, oseltamivir, Date of authorisation: 20/06/2002, Revision: 43, Status: Authorised
Human medicines European public assessment report (EPAR): Tamiflu, oseltamivir, Date of authorisation: 20/06/2002, Revision: 43, Status: Authorised
Read More

Tags:

Previous Article

STAT+: Harvard scientist ordered to halt multicenter TB trial in funding freeze

Next Article

Human medicines European public assessment report (EPAR): Inovelon, rufinamide, ...

Related Posts

Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 93, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 20, 2025  0

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 40, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025  0

Human medicines European public assessment report (EPAR): Siiltibcy, Mycobacterium tuberculosis derived antigens (rdESAT-6 / rCFP-10), Date of authorisation: 13/01/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 24, 2025  0